![Eugene Park](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Eugene Park formerly worked at Immunomedics, Inc., as Head-Marketing from 2018 to 2019, Halozyme Therapeutics, Inc., as Head-Marketing from 2019 to 2020, Coherus Oncology, Inc., as Vice President-Marketing, and Lite Strategy, Inc., as VP-Portfolio Strategy & New Product Planning.
Mr. Park received his undergraduate degree from Massachusetts Institute of Technology and Masters Business Admin degree from Columbia Business School.
Precedenti posizioni note di Eugene Park
| Società | Posizione | Fine |
|---|---|---|
| COHERUS ONCOLOGY, INC. | Vendite & Marketing | 01/06/2021 |
| HALOZYME THERAPEUTICS, INC. | Vendite & Marketing | 01/01/2020 |
| IMMUNOMEDICS, INC. | Vendite & Marketing | 01/03/2019 |
| LITE STRATEGY, INC. | Corporate Officer/Principal | - |
Formazione di Eugene Park
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
6
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
MEI Pharma, Inc.
 MEI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Coherus BioSciences, Inc.
 Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
